SCAT trial: Phase III Spanish customized adjuvant treatment according BRCA1 mRNA levels in stage II-IIIA non-small cell lung cancer.

Authors

null

B. Massuti

Medical Oncology Alicante University Hospital, Alicante, Spain

B. Massuti , U. Jimenez , J. M. Rodriguez Paniagua , Y. W. Pun , M. Cobo , E. Carcereny Costa , R. Arrabal , J. Astudillo , I. C. Barneto , R. De Las Penas , C. Baamonde , G. Sales , J. Gonzalez-Larriba , G. Lopez-Vivanco , F. Hernando-Trancho , J. Pac , A. Artal-Cortes , J. Rivas , R. Rosell , J. M. Sanchez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session

Track

Special Sessions,Clinical Trials

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT00478699

Citation

J Clin Oncol 29: 2011 (suppl; abstr TPS208)

Abstract #

TPS208

Poster Bd #

49F

Abstract Disclosures